2013, English, Book, Illustrated
South Australian gastroenteropancreatic neuroendrocrine tumours pathway : optimising outcomes for all South Australians diagnosed with gastroenteropancreatic neuroendrocrine tumours.
"The Pathway adopts a multidisciplinary approach to the care of people affected by NETs with involvement of all relevant health professionals. The pathway sets out key requirements for the provision of optimal care which needs to be considered in the NET patient journey. However, it should be noted that not all patients will progress through each step of the pathway. This is a consequence of many factors, including disease outcomes, management decisions, and patient decisions. The pathway is a statement of consensus based on current best practice, evidence and accepted approaches to cancer treatment and management. Recommendations should be followed subject to the health professional's independent medical judgment and the patient's preference in each individual case. The scope of these guidelines is to focus on well- to poorly-differentiated gastroenteropancreatic neuroendocrine tumours (GEP NETs). Given the limited availability of high-level randomised trials evidence in the clinical management of GEP NETs, the pathway and recommendations have been developed based on currently available national and international guidelines, while ensuring relevance and appropriateness to local practice."--From Executive Summary.
"This clinical cancer pathway was developed by the Neuroendocrine Tumours Working Party under the auspices of the Statewide Cancer Clinical Network. The project was funded by UNICORN FOUNDATION. The Unicorn Foundation is the only Australian not-for-profit organisation focused on Neuroendocrine Tumours (NET)."--Title page verso.
Includes bibliographical references (pages 104-111)
In order to set up a list of libraries that you have access to,
you must first login
or sign up.
Then set up a personal list of libraries from your profile page by
clicking on your user name at the top right of any screen.